DiRaimondo Thomas
SEC CIK 2005618 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | CSO | 124.4K | — | $266.1K | 4 | 2024-09-27 | 2026-01-02 |
Most active insiders at JANX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meyer Andrew Hollman | Chief Business Off | — | $736.7K |
| 2 | Campbell David Alan | Pres, CEO, Dir | — | $110.8K |
| 3 | Doyle Janeen Noel | Chief Corp, Bus. Dev. Ofcr | — | $56.9K |
| 4 | Dobek Maria | VP, Accounting | — | $49.0K |
| 5 | McIver Zachariah | Chief Medical Off | — | $37.3K |
| 6 | DiRaimondo Thomas | CSO | — | $34.4K |
| 7 | Winter Charles M. | Chief Technical Off | — | $33.0K |
| 8 | Go William | Chief Medical Off | — | — |
| 9 | Simson Jake | Dir | — | — |
| 10 | Hernday Natasha | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-02 | 2026-01-02 | JANX | Janux Therapeutics, Inc. | DiRaimondo Thomas | CSO | S - Sale | $13.73 | -2,505 | 124.4K | -2% | -$34.4K |
| D | 2026-01-02 | 2026-01-02 | JANX | Janux Therapeutics, Inc. | DiRaimondo Thomas | CSO | A - Grant | $0.00 | +31.4K | 155.8K | +25% | $0 |
| D | 2025-01-03 | 2025-01-02 | JANX | Janux Therapeutics, Inc. | DiRaimondo Thomas | CSO | A - Grant | $0.00 | +24.0K | 129.7K | +23% | $0 |
| M | 2024-09-27 | 2024-09-27 | JANX | Janux Therapeutics, Inc. | DiRaimondo Thomas | CSO | S - Sale | $46.35 | -5,000 | 97.9K | -5% | -$231.7K |
Purchase Sale Sale after option exercise All abbreviations